|
Pharmacokinetics, Safety, and Tolerability of
Obeldesivir (OBV; GS-5245) in Healthy Participants
|
|
|
Poster presented at the 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); 15-18 April 2023
Olena Anoshchenko,* Mazin Abdelghany, Robert H. Hyland, Santosh Davies, Christine Mkaya, Gong Shen, Deqing Xiao, Helen Winter, Joe Llewellyn, Rita Humeniuk
Gilead Sciences, Inc., Foster City, CA, USA.
|
|
|
|
|
|
|